glp-1 obesity drug news today october 23 2025 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response The Obesity-Drug Revolution Is Stalling
Description
Variants like GIPR rs1800437 affect GIP receptor function and predict differential response to tirzepatide versus semaglutide
Sung, H., Siegel, R
Visit Ro.co for more information.
These trials are mostly based on composite reductions in MACEs (similar to the original ELIXA trial endpoint)
30 Hence, there is significant interest in the development of small-molecule GLP-1R agonists
Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, et al
